Download Biochemistry & Clinical Pathology (ER20-23T) Model Paper D. Pharma 2nd Year

Welcome to Pharmacy India, your premier destination for cutting-edge pharmaceutical education resources! 🌟 Embark on a journey through Biochemistry & Clinical Pathology with our ER20-23T Model Paper tailored for D. Pharma 2nd Year. Elevate your exam preparation and deepen your understanding of vital biochemical and clinical principles with these meticulously crafted resources.

Apply for Work from Home Regulatory Consultant / Sr Reg Consultant (CMC- API) at Syneos Health – B. Pharma/ M. Pharma/ Lifescience/ Ph. D

Syneos Health is the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success. We lead with a product development mindset, seamlessly connecting our capabilities to add high-value insights to speed therapies to patients and provide practical value to help…

Merck gives an update from the phase 2 KeyVibe-002 trial of MK-7684A, a coformulation of vibostolimab with pembrolizumab, in patients with metastatic NSCLC who have already received treatment.

The open-label portion of the non-registrational phase 2 KeyVibe-002 trial received an update from Merck, also known as MSD outside of the United States and Canada. For the treatment of patients with metastatic non-small cell lung cancer (NSCLC) who have…

Oxford Nanopore and Cyclomics start testing a non-invasive technique for the rapid and precise detection of compounds linked to cancer.

Netherlands startup and Oxford Nanopore Technologies The world’s first nanopore sequencing-based technology for ultra-sensitive detection of circulating tumour DNA has been made available to developers by Cyclomics (ctDNA). The procedure finds and evaluates cell-free DNA (cfDNA) in the blood. As…

Registration Form


This will close in 0 seconds

WhatsApp Telegram